Dr. James Peyer of ApolloVC discussed tactical paths to bring longevity promoting therapeutics to market as quickly as possible. The cost of developing a drug is $2.6 billion. Pharma companies need to have each successful drug approved has to pay for ten failed drugs. Each drug from discovery through clinical trials averages out to a cost of $260 million. Anti-aging companies and anti-aging investors need to focus on an initial aging disease to get approval to treat. They then target a second and third anti-aging disease. After that they can look at trying to follow metformin for general anti-aging approval.
The post Successful anti-aging would be over ten times better than curing all cancer appeared first on NextBigFuture.com.
Comments
Post a Comment